+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Recurrent ischemia after successful reperfusion for acute myocardial infarction effect of treatment on mortality



Recurrent ischemia after successful reperfusion for acute myocardial infarction effect of treatment on mortality



Circulation 82(4 Suppl. 3): III86




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033119881

Download citation: RISBibTeXText


Related references

Treatment of recurrent ischemia after thrombolysis and successful reperfusion for acute myocardial infarction effect of in hospital mortality and left ventricular function. Journal of the American College of Cardiology 17(3): 752-757, 1991

The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?. European Journal of Heart Failure 4(4): 501-506, 2002

Incidence and predictors of early recurrent ischemia after successful percutaneous transluminal coronary angioplasty for acute myocardial infarction. American Journal of Cardiology 63(5): 263-268, 1989

Reperfusion arrhythmias: are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction?. Angiology 58(6): 663-670, 2007

B-type natriuretic peptide as a predictor of ischemia/reperfusion injury immediately after myocardial reperfusion in patients with ST-segment elevation acute myocardial infarction. European Heart Journal. Acute Cardiovascular Care 5(1): 62-70, 2016

Ischemia-reperfusion injury is still a big hurdle to overcome for treatment of acute myocardial infarction. Journal of Cardiology 67(4): 305-306, 2016

Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. American Heart Journal 158(5): 755-760, 2009

Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: A comparison of thrombolytic therapy and primary angioplasty. Journal of the American College of Cardiology 26(1): 66-72, 1995

Impact of n-3 polyunsaturated fatty acids in predicting ischemia/reperfusion injury and progression of myocardial damage after reperfusion in patients with ST-segment elevation acute myocardial infarction. Journal of Cardiology 66(2): 101-107, 2015

Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group. Lancet 350(9078): 615-619, 1997

Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: a Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment - Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial. Canadian Journal of Cardiology 25(12): E399-E405, 2009

Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction. Japanese Circulation Journal 62(3): 183-189, 1998

Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial. American Heart Journal 154(6): 1078-84 1084.E1, 2007